Kawakami H, Sunakawa Y, Inoue E, Matoba R, et al. Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial. Eur J Cancer 2023;184:10-20.
PMID: 36889037